Basic Information
LncRNA/CircRNA Name | DANCR |
Synonyms | NA |
Region | GRCh38_4:52712404-52720351 |
Ensemble | ENSG00000226950 |
Refseq | NR_024031 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | bladder cancer |
ICD-0-3 | C67 |
Methods | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RNAi, RIP, etc. |
Sample | snap-frozen fresh BCa tissues, human BCa cells UMUC-3 and T24 and SV40-transformed kidney cell line 293T |
Expression Pattern | up-regulated |
Function Description | DANCR was significantly upregulated in BCa tissues and cases with LN metastasis. DANCR expression was positively correlated with LN metastasis status, tumor stage, histological grade, and poor patient prognosis. Functional assays demonstrated that DANCR promoted BCa cell migration, invasion, and proliferation in vitro and enhanced tumor LN metastasis and growth in vivo. Mechanistic investigations revealed that DANCR activated IL-11-STAT3 signaling and increased cyclin D1 and PLAU expression via guiding leucine-rich pentatricopeptide repeat containing (LRPPRC) to stabilize mRNA. Moreover, oncogenesis facilitated by DANCR was attenuated by anti-IL-11 antibody or a STAT3 inhibitor (BP-1-102). In conclusion, our findings indicate that DANCR induces BCa LN metastasis and proliferation via an LRPPRC-mediated mRNA stabilization mechanism. DANCR may serve as a multi-potency target for clinical intervention in LN-metastatic BCa. |
Pubmed ID | 30660488 |
Year | 2019 |
Title | DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression |
External Links
Links for DANCR | GenBank HGNC NONCODE |
Links for bladder cancer | OMIM COSMIC |